Answers are grounded in this paper and cite their sources.
Comparing the effects of mitomycin-C on healing and blockage rates in dacryocystitis patients.
Aim-To compare outcomes of endoscopic dacryocystorhinostomy (DCR) with and without intraoperative mitomycin-C (MMC) application. Methodology- 50 patients selected randomly for endoscopic DCR, 23 with right eye involvement, 13 with left, and 14 with bilateral dacryocystitis. Patients included between age group 15-75 years, both genders, having unilateral or/and bilateral chronic dacryocystitis. Patients with acute dacryocystitis, canalicular obstruction, granulomatous systemic diseases, malignancies of the nose or lacrimal sac, and congenital or traumatic lacrimal obstruction were excluded. Using a simple randomization method, 25 patients underwent DCR with intraoperative MMC (Group A) and 25 without MMC (Group B). By 3 months, subjective relief was noted in all except one patient in Gro Results- up A and two in Group B. Objective assessment by sac syringing showed full patency in all patients at 1-week. However at 2-weeks and 1-month, partial blockages occurred in one patient from Group A and two from Group B. Granulation tissue was minimal in Group A (only one case at 2-weeks) and more persistent in Group B, suggesting better healing with MMC. MMC may enhance ostium patency and reduce granulation tissue Conclusion- formation. However, with ongoing improvements in endoscopic DCR, further large-scale studies are needed to validate its routine use.
No takes yet. Share an insight, caveat, or question.
Bangera et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: